http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20150042344-A
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N5-0696 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N5-0606 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N5-0018 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-867 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-867 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-074 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-0775 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-10 |
| filingDate | 2013-10-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2015-04-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-20150042344-A |
| titleOfInvention | Induced pluripotent stem cell transfected by reprogramming factor into CD105- cell and method for preparing the same |
| abstract | The present invention relates to an inducible pluripotent stem cell into which CD105 - cells have been introduced with a reprogramming factor and a method for producing the same. IPS cells according to the invention is CD105 - cell de-differentiation factor is introduced by being, CD105 + cells, de-differentiation factors differentiation station than when the introduction forming efficiency and the colonies developed are excellent, and expressing the marker gene of the stem cells in the And can be differentiated into endoderm, mesoderm and ectoderm, and thus can be usefully used as a cell therapy agent. |
| priorityDate | 2013-10-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 280.